Inge Christoffer Olsen

6PUBLICATIONS
43CO-AUTHORS
Epidemiological methodsMajor global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 06, 2026
Heterogeneous treatment effect estimation with instrumental variable methods.

|Nov 12, 2024
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis.

Thale D J Hovdun Patrick-Brown, Andreas Barratt-Due, Marius Trøseid

|Nov 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients.

Synne Jenum, Kristian Tonby, Corina S Rueegg

|Jul 12, 2021
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.

Andreas Barratt-Due, Inge Christoffer Olsen, Katerina Nezvalova-Henriksen

|May 16, 2018
Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.

Ingvild Vik, Marianne Bollestad, Nils Grude

Pageof 1

Frequent Collaborators

3 joint publications

Anne Ma Dyrhol-Riise

2 joint publications

Marius Trøseid

2 joint publications

Pål Aukrust

1 joint publications

Thale D J Hovdun Patrick-Brown